Requires health insurance coverage for testing for BRCA1 and BRCA2 genes.
Impact
The implications of A5743 on state law are substantial, as it modifies existing regulations concerning health insurance coverage by specifically mandating the inclusion of genetic testing for two critical breast cancer-related genes. This legislation is poised to ease access to preventive measures for individuals who may be at risk. By ensuring that health insurance providers cover the costs associated with these tests, the bill could potentially lead to a reduction in late-stage breast cancer diagnoses and improve early detection and treatment outcomes for women in New Jersey.
Summary
Assembly Bill A5743 mandates that health insurance policies in New Jersey must cover the costs of testing for the BRCA1 and BRCA2 genes, which are significant genetic markers associated with breast cancer. This bill, if enacted, applies to all health insurance contracts that are delivered, issued, executed, or renewed after the effective date of the legislation. The requirement emphasizes that such testing will be treated with the same level of coverage as any other medical condition under the individual health plans.
Contention
While the bill is likely to receive support from health advocacy groups and individuals concerned with breast cancer awareness, there may be opposition from insurance companies wary of the financial implications of mandated testing. The debate may center around the cost-effectiveness of such testing, its necessity for all policyholders, and the influence it may exert on premium rates for health plans. Stakeholders will likely discuss whether genetic testing should be universally covered or reserved for individuals with a family history of breast cancer, highlighting the ongoing tension between comprehensive healthcare coverage and cost management in the insurance industry.
In casualty insurance, repealing provisions relating to coverage for mammographic examinations and breast imaging and providing for coverage for mammographic examinations, magnetic resonance imaging and other forms of breast imaging.